LAMEA Autoimmune Disease Therapeutics Market By Indication (Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications) By Drug Class (Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs Nonsteroidal anti-inflammatory drugs, Interferons and Other Drugs) By the Distribution Channel (Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores)

Analysis of Market Size & Trends

The Latin America, Middle East and Africa Autoimmune Disease Therapeutics Market would witness market growth of 5.38% CAGR during the forecast period (2019-2025).

Autoimmune diseases are usually chronic and there's no curative treatment for them. Dermatomyositis, Hashimoto's disease of type 1 diabetes, Sjogren's syndrome, Psoriasis are some examples of autoimmune diseases. Systemic treatment of autoimmune diseases and localized treatment of autoimmune disease are two kinds of treatments for autoimmune disease.

The accelerated acceptance of autoimmune disease therapeutics expanded wide accessibility of sophisticated therapy, and an increase in the number of research and development operations are collectively driving the market growth. High original expenses linked to sophisticated therapies, however, restrict the market growth. On the other side, the powerful existence of pipeline drugs and possibilities in emerging economies creates new sector routes.

Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Click Here For Free Insights

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Scope of the Autoimmune Disease Therapeutics Market Analysis

Market Segmentation:

By Indication

• Rheumatic Disease
• Diabetes
• Multiple Sclerosis
• Inflammatory Bowel Disease
• Other Indications

By Drug Class

• Anti-Inflammatory
• Anti-Hyperglycemics
• NSAIDs
• Interferons
• Other Drugs

By Distribution Channel

• Hospital Pharmacy
• Online
• Retail Pharmacies and Drug Stores

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• ABBOTT Laboratories
• Bio-Rad Laboratories, Inc.
• Johnson and Johnson
• GlaxoSmithKline PLC (GSK)
• Pfizer, Inc.
• Merck & Co., Inc.
• Bayer AG
• AbbVie, Inc.
• Amgen, Inc.
• Novartis AG